• 1. School of Biology and Engineering, Guizhou Medical University, Guiyang 550025, P.R.China;
  • 2. Key laboratory of Biology and Engineering, Guizhou Medical University, Guiyang 550025, P.R.China;
ZENG Zhu, Email: zengzhu100@sina.com
Export PDF Favorites Scan Get Citation

Dendritic cells (DCs) are the most potent and specialized antigen-presenting cells (APCs) currently known, which play a crucial role in initiating and amplifying both the innate and adaptive immune responses. During the process of immune function, migration ability of DCs and the number of effector T cells which activated by DCs are closely related to the efficiency of immune function. However, because of the complexity of immune system, in the immune response process caused by the skin chronic inflammatory, much is still unknown about the dynamic changes of cell count with time. Therefore, we created a differential equations model to reflect the initial stages of the immune response process caused by the skin chronic inflammatory via setting the function and initial conditions of parameters. The results showed that the model was able to simulate migration and proliferation of cells in vivo within realistic time scales in accordance with the proliferation and migration efficiency in real terms. In addition, the preliminary model can biologically predict the realistic dynamics of DCs and T cells at different time points. All these results may provide a theoretical reference for studying the immune function of DCs as well as guiding the clinical treatment for immune related diseases further.

Citation: HU Wenhui, HUANG Wenzhu, HU Zuquan, ZENG Zhu. A numerical simulation of dendritic cells migration and induction of T cell specific proliferation during the initiation of skin inflammatory. Journal of Biomedical Engineering, 2017, 34(5): 797-802. doi: 10.7507/1001-5515.201702050 Copy

  • Previous Article

    Computer-assisted quantitative analysis of contrast-enhanced ultrasonography in Takayasu arteritis carotid artery lesions
  • Next Article

    Caveolin-1 in relation with mitochondria and cancer metabolism—a promising target for cancer therapy